209 results on '"Maxim, P.G."'
Search Results
2. Technical Infrastructure for Clinical Translation of Electron FLASH
3. Clinical LINAC-Based Electron FLASH: Pathway for Practical Translation to Trials of FLASH Radiotherapy
4. Lymphocyte Nadir Following Radiation for Soft-Tissue Sarcoma: Defining Key Dosimetric Parameters and Outlining Clinical Significance
5. Assessing Clinical Feasibility of a LINAC-Based Electron FLASH Radiotherapy System Using an Anthropomorphic Phantom under Realistic Clinical Conditions
6. Observation of Acute Toxicity Events in Lung Cancer Patients Treated Concurrently with a Tyrosine Kinase Inhibitor
7. A 10-Center Prospective Clinical Trial of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for Anesthesia Avoidance in Pediatric Patients
8. Validation of a Novel Cone-Less Set-up for Electron FLASH Radiation Delivery on a Clinical-Use Linear Accelerator
9. Feasibility of Clinically Practical Ultra-High Dose Rate (FLASH) Radiation Delivery by a Reversible Configuration of a Standard Clinical-Use Linear Accelerator
10. Phase I Trial of Dose-Escalated Five-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Lung Squamous Cell Carcinoma
11. A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR)
12. Cardiac Toxicities and Outcomes Following Stereotactic Ablative Radiation to Thoracic Cancers
13. Pre-Treatment Lung FDG-PET Uptake is Correlated with Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR)
14. Parametric Response Mapping as an Imaging Biomarker for Regional Ventilation in Stereotactic Ablative Radiotherapy
15. Investigating and Validating Metabolic Tumor Volume As a Prognostic Factor for Local Recurrence in Early Stage Lung Cancer
16. Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy
17. Predicting Hematologic Toxicity of Anal Cancer Patients before Chemoradiation Using Deep Residual Network with Transfer Learning
18. Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience
19. Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR)
20. Exploiting Tumor Position Differences between Deep Inspiration and Expiration in Lung Stereotactic Body Radiation Therapy Planning
21. Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus
22. Pulmonary Interstitial Lymphography and Patterns of Recurrence after Stereotactic Ablative Radiation Therapy(SABR) of Lung Tumors
23. Predicting Per-Lesion Local Recurrence in Locally Advanced Lung Cancer using Metabolic Tumor Volume on Pre- and Mid-Radiation FDG-PET
24. Radiologic Quantification and Predictors of Lung Fibrosis after Stereotactic Ablative Radiation Therapy(SABR)
25. 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy
26. Mid-radiation Therapy PET/CT for Prognostication and Detection of Early Progression in Patients With Stage III Non–small Cell Lung Cancer
27. Validation of Temporal Change in Quantitative PET Metrics as Predictors of Recurrence in Early Stage Lung Cancer Patients Treated With SABR
28. Outcomes of Moderately Hypofractionated Intensity-Modulated Thoracic Radiotherapy with Concurrent Chemotherapy for Treatment of Non–Small Cell Lung Cancer
29. Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors
30. Impact of Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) on Anesthesia Use, Cost, and Time in Pediatric Patients
31. Vesselness-Based Deformable Registration Algorithms Can Reduce Landmark Errors in the Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy
32. Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
33. Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors
34. Temporal Change in Quantitative Positron Emission Tomography Metrics Predicts Recurrence in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy
35. Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors
36. Acceptable Toxicity Is Observed Following Retreatment of Thoracic Malignancies: Dose Volume Toxicity Data for Repeat Radiation Therapy
37. Pretreatment FDG Uptake of Non-Target Lung Tissue is Significantly Associated With Radiation Pneumonitis Following Stereotactic Ablative Radiation Therapy (SABR)
38. Imaging Based Parameters Associated With Disease Progression of Early-Stage NSCLC Treated With Surgical Resection
39. Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration
40. Vertebral Fractures After Stereotactic Ablative Radiation Therapy of Lung Tumors
41. Optimization of Beam Parameters for Very High-Energy Electron Radiation Therapy: A Lung Cancer Case
42. Treatment-Planning Study for Very High-Energy Electron Beam Radiation Therapy: Integral Dose Reduction for Pediatric Patients
43. First in Human High-Resolution Imaging of Regional Lung Function by Single Energy Xenon CT Compared to Ventilation SPECT
44. Impact of Very Rapid Irradiation on Clonogenic Survival
45. Performance of PET in Evaluating Local Recurrence After Stereotactic Ablative Radiation Therapy for Early Lung Cancer
46. Prognostic Metrics on Serial PET for Lung Tumors Treated With Hypofractionated Radiation
47. Lung Tumor Stereotactic Ablative Radiation Therapy With Individualized Anatomic Optimization
48. Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
49. Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
50. Can Use of an Atlas Decrease Contouring Variability in Non-small Cell Lung Cancer Radiation Therapy? Analysis of the RTOG 1106 Preclinical Trial Planning Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.